Incidence and Natural History of Paget's Disease of Bone in England and Wales
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
This study used a large, primary care, record-linkage resource (the General Practice Research Database [GPRD]) to evaluate the incidence, clinical presentation, and natural history of Paget's disease of bone in England and Wales. Between 1988 and 1999, we identified 2465 patients with the recorded diagnosis of Paget's disease of bone, within the five million subjects ≥18 years old who were registered in the GPRD. The validity of diagnostic recording was assessed by questionnaire to individual general practitioners (GPs) in 150 patients; the diagnosis was confirmed in 93.8% of responders. The mean age of patients with Paget's disease was 75 years and 51% were men. The prevalence of the disorder was 0.3% among men and women aged ≥55 years; incidence rates for clinically diagnosed Paget's disease rose steeply with age (men, 5 per 10,000 person-years; women, 3 per 10,000 person-years at the age of 75 years). Over the 11-year period of the study, the age- and sex-adjusted incidence rate of clinically diagnosed Paget's disease declined from 1.1 per 10,000 person-years to 0.7 per 10,000 person-years. Each patient with Paget's disease was matched to three controls matched by age, gender, and general practice. Cases had a greater risk of back pain (relative risk [RR], 2.1; 95% CI, 1.9-2.3), osteoarthritis (OA; RR, 1.7; 95% CI, 1.5-1.9), hip arthroplasty (RR, 3.1; 95% CI, 2.4-4.1), knee arthroplasty (RR, 1.6; 95% CI, 1.0-2.6), fracture (RR, 1.2; 95% CI, 1.0-1.5), and hearing loss (RR, 1.6; 95% CI, 1.3-1.9). Seven patients with Paget's disease developed a malignant bone neoplasm (0.3%). Using life table methodology, the estimated number of people who died within 5 years of follow-up was 32.7% among the patients with Paget's disease and 28.0% among the control patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic Research: Principles and Quantitative Methods.
Pocock, S. J., Kleinbaum, D. G., Kupper, L. L., & Morgenstern, H. (1983) · Biometrics · doi:10.2307/2531133 · Cited by 1,893
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839 · cited 1×
“(11,12) The GPRD is owned by the Department of Health and managed by the Medicines Control Agency in the United Kingdom.”
The UK General Practice Research Database
Walley, T., & Mantgani, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04248-7 · Cited by 623
Pathophysiology and Treatment of Paget's Disease of Bone
Kanis, J. А. (1991) · Medical Entomology and Zoology · Cited by 308
The Epidemiology of Paget's Disease in Britain: Is the Prevalence Decreasing?
Prof. Cooper, C., Schafheutle, K., Dennison, E., Kellingray, S., Guyer, P., & Barker, D. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.2.192 · Cited by 246
Self-citationSarcomas of bone complicating osteitis deformans (Pagetʼs disease): Fifty yearsʼ experience
Wick, M. R., McLeod, R. A., Siegal, G. P., Greditzer, H. G., & Unni, K. K. (1981) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198101000-00008 · Cited by 183
Van Staa, T. P., Abenhaim, L., Cooper, C., Zhang, B., & Leufkens, H. G. M. (2000) · Pharmacoepidemiology and Drug Safety · doi:10.1002/1099-1557(200009/10)9:5<359::aid-pds507>3.0.co;2-e · Cited by 157
Self-citationSiris, E. S. (1994) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(94)90037-x · Cited by 128
THE EPIDEMIOLOGY OF PAGET'S DISEASE OF BONE
BARKER, D. J. P. (1984) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072011 · Cited by 121
Long-term trends in the incidence of Paget’s disease of bone
Tiegs, R. D., Lohse, C. M., Wollan, P. C., & Melton, L. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00333-1 · Cited by 120
Cited by
Validity of diagnostic coding within the General Practice Research Database: a systematic review
Khan, N. F., Harrison, S. E., & Rose, P. W. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483562 · Cited by 685
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease.
Hocking, L. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2735 · Cited by 350
“Whilst many patients are asymptomatic, others present with bone pain, deformity, pathological fracture, deafness, nerve compression syndromes and osteoarthritis (4).”
BackgroundLewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1115 · Cited by 341
Roodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340
“fact that the incidence and severity of the disease has been changing over the last 25 years (83, 84) all support the hypothesis that additional, nongenetic factors are involved in the development”
BackgroundPathogenesis and management of Paget's disease of bone
Ralston, S. H., Langston, A. L., & Reid, I. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61035-1 · Cited by 260
Paget's Disease of Bone: An Endocrine Society Clinical Practice Guideline
Singer, F. R., Bone, H. G., Hosking, D. J., Lyles, K. W., Murad, M. H., Reid, I. R., & Siris, E. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2910 · Cited by 194
Self-citationThe fracture mechanics of human bone: influence of disease and treatment
Zimmermann, E. A., Busse, B., & Ritchie, R. O. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.112 · Cited by 164
“However, despite the bowing and cracking, the overall fracture risk to patients is low, and fracture events at pathological skeletal sites are uncommon (occurring in B2% of patients).(73,74) For Paget’s disease to produce the marked changes in bone’s mechanical integrity (that is, bowing and deformities) at the macros…”
BackgroundLong-Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate
Hosking, D., Lyles, K., Brown, J. P., Fraser, W. D., Miller, P., Curiel, M. D., Devogelaer, J.-P., Hooper, M., Su, G., Zelenakas, K., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061001 · Cited by 161
“Long-term control of disease activity is also an important goal of treatment because of the possibility that this might reduce the risk of long-term complications such as deformity, fracture, and degenerative joint disease.((7))”
BackgroundSelf-citationHocking, L. J., Lucas, G. J., Daroszewska, A., Cundy, T., Nicholson, G. C., Donath, J., Walsh, J. P., Finlayson, C., Cavey, J. R., Ciani, B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0403015 · Cited by 156
“1% individuals over 55 years of age in the United Kingdom.((1)) The cause of PDB is incompletely understood, but genetic factors play an important role, reflected by the fact that between 15% and”
BackgroundInfluentialManagement of Paget's disease of bone
Langston, A. L. (2004) · Rheumatology · doi:10.1093/rheumatology/keh243 · Cited by 124
Rea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T., & Xu, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1034 · Cited by 123
SQSTM1 and Paget?s Disease of Bone
Layfield, R., & Hocking, L. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0041-0 · Cited by 76
“Although many patients are asymptomatic, 30% experience bone pain, skeletal deformity, deafness, neurological symptoms, and pathological fractures [2].”
Metadata
- Authors
- Van Staa, T. P., Selby, P., Leufkens, H. G. M., Lyles, K., Sprafka, J. M., & Prof. Cooper, C.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-03-01
- Volume
- 17
- Issue
- 3
- Pages
- 465-471
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2016084217
- Cited by
- 369
- References
- 17
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.